The present invention discloses a composition for dermatological
infections by the use of a lytic enzyme in a carrier suitable for topical
application to dermal tissues. The method for the treatment of
dermatological infections comprises administering a composition
comprising effective amount of a therapeutic agent, with the therapeutic
agent comprising a lytic enzyme produced by infecting a bacteria with
phage specific for that bacteria.